A detailed history of Quantbot Technologies LP transactions in Organon & Co. stock. As of the latest transaction made, Quantbot Technologies LP holds 75,456 shares of OGN stock, worth $661,749. This represents 0.04% of its overall portfolio holdings.

Number of Shares
75,456
Holding current value
$661,749
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$14.29 - $16.41 $1.08 Million - $1.24 Million
75,456 New
75,456 $1.12 Million
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $110,109 - $135,969
5,904 New
5,904 $112,000
Q3 2022

Nov 07, 2022

BUY
$23.4 - $34.25 $21,879 - $32,023
935 New
935 $21,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $2.23B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.